Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Mar 26;4(4):e001896.
doi: 10.1161/JAHA.115.001896.

Glucocorticoid therapy for Duchenne cardiomyopathy: A Hobson's choice?

Subha V Raman  1 , Linda H Cripe  2
Affiliations
Editorial

Glucocorticoid therapy for Duchenne cardiomyopathy: A Hobson's choice?

Subha V Raman et al. J Am Heart Assoc. .
No abstract available

Keywords: Duchenne muscular dystrophy cardiomyopathy; Editorials; Glucocorticoid; cardiac magnetic resonance imaging.

PubMed Disclaimer

Comment on

References

    1. Voltaire In: Tallentyre S. (ed.). Letter to Frederick William, Prince of Prussia (28 November 1770). Voltaire in His Letters. 1919New York, NY: G.P. Putnam's Sons; 1919
    1. Menon SC, Etheridge SP, Liesemer KN, Williams RV, Bardsley T, Heywood MC, Puchalski MD. Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy. Pediatr Cardiol. 2014; 35:1279-1285. - PubMed
    1. Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A, Berard C, Vaksmann G, Weber S, Bécane H. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow‐up. Am Heart J. 2007; 154:596-602. - PubMed
    1. Rhodes J, Margossian R, Darras BT, Colan SD, Jenkins KJ, Geva T, Powell AJ. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr Cardiol. 2008; 29:343-351. - PubMed
    1. Tandon A, Villa CR, Hor KN, Jefferies JL, Gao Z, Towbin JA, Wong BL, Mazur W, Fleck RJ, Sticka JJ, Benson DW, Taylor MD. Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in Duchenne muscular dystrophy. J Am Heart Assoc. 2015; 4:e00133810.1161/JAHA.114.001338 - PMC - PubMed

Substances